Page 6 - Seth Lederman News Today

Patients with fibromyalgia who receive a sublingual tablet form cyclobenzaprine experience reduced daily pain, and improved sleep quality, compared with those who received placebo, according to a press release from the drug’s manufacturer.

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive studios to share the findings of two publications in the...

A STAT and MuckRock investigation shows the NIH hasn’t picked up the pace on its long Covid research. Instead, the delays have compounded.

Maryland Democrats have proposed legislation aimed at addressing educational inequities and eliminating academic achievement gaps.

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive newsroom to share its new research agreement with...

22.02.2023 - Symptoms of Long COVID, Like Multi-Site Pain, Fatigue and Insomnia, are the Hallmarks of Chronic Pain Syndromes Like Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) Event Co-Hosted by the Biotechnology Innovation ... Seite 1

13.02.2023 - Immunocompromised Individuals, Including Organ Transplant Recipients, Are at Increased Risk of Severe COVID-19 and Poor Clinical Outcomes SARS-CoV-2 has Mutated to Evade the Formerly EUA-Approved Monoclonal Antibody Therapies and Preventatives ... Seite 1

NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street / Newsmax TV announces the broadcasting line-up of its nationally syndicated...

06.02.2023 - Results from Planned Interim Analysis Expected Fourth Quarter 2023 Approximately Four Million in U.S. Suffer from Chronic Migraine Development of TNX-1900 Also Planned for Treatment of Episodic Migraine CHATHAM, N.J., Feb. 06, 2023 (GLOBE ... Seite 1

Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, today announced that it has entered into a sponsored research agreement with the University of Maryland, Baltimore ,... | February 2, 2023